480 related articles for article (PubMed ID: 23535159)
1. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.
Marx A; Pfister F; Schalke B; Saruhan-Direskeneli G; Melms A; Ströbel P
Autoimmun Rev; 2013 Jul; 12(9):875-84. PubMed ID: 23535159
[TBL] [Abstract][Full Text] [Related]
2. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
[TBL] [Abstract][Full Text] [Related]
3. [Seronegative myasthenia gravis].
Gajdos P
Rev Neurol (Paris); 2004 Feb; 160(2):159-62. PubMed ID: 15034472
[TBL] [Abstract][Full Text] [Related]
4. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis.
Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A
Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930
[TBL] [Abstract][Full Text] [Related]
5. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
Berrih-Aknin S; Le Panse R
Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
7. Reflections on the "intrathymic pathogenesis" of myasthenia gravis.
Hohlfeld R; Wekerle H
J Neuroimmunol; 2008 Sep; 201-202():21-7. PubMed ID: 18644632
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis with anti-acetylcholine receptor antibodies.
Meriggioli MN
Front Neurol Neurosci; 2009; 26():94-108. PubMed ID: 19349707
[TBL] [Abstract][Full Text] [Related]
10. [Autoantibodies detected in acetylcholine receptor antibody-negative myasthenia gravis].
Ohta R; Motomura M
Rinsho Byori; 2014 Mar; 62(3):255-60. PubMed ID: 24800501
[TBL] [Abstract][Full Text] [Related]
11. Myasthenia gravis.
Marx A; Schultz A; Wilisch A; Nenninger R; Müller-Hermelink HK
Verh Dtsch Ges Pathol; 1996; 80():116-26. PubMed ID: 9020569
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
13. The auto-antigen repertoire in myasthenia gravis.
Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
[TBL] [Abstract][Full Text] [Related]
14. Thymus, thymoma and myasthenia gravis.
Fujii Y
Surg Today; 2013 May; 43(5):461-6. PubMed ID: 22948665
[TBL] [Abstract][Full Text] [Related]
15. The thymus in myasthenia gravis: Site of "innate autoimmunity"?
Cavalcante P; Le Panse R; Berrih-Aknin S; Maggi L; Antozzi C; Baggi F; Bernasconi P; Mantegazza R
Muscle Nerve; 2011 Oct; 44(4):467-84. PubMed ID: 21922466
[TBL] [Abstract][Full Text] [Related]
16. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
Saka E; Topcuoglu MA; Akkaya B; Galati A; Onal MZ; Vincent A
Neurology; 2005 Sep; 65(5):782-3; author reply 782-3. PubMed ID: 16157930
[No Abstract] [Full Text] [Related]
17. Biological implications of thymectomy for myasthenia gravis.
Okumura M; Inoue M; Kadota Y; Hayashi A; Tokunaga T; Kusu T; Sawabata N; Shiono H
Surg Today; 2010; 40(2):102-7. PubMed ID: 20107947
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of myasthenia gravis.
Marx A; Wilisch A; Schultz A; Gattenlöhner S; Nenninger R; Müller-Hermelink HK
Virchows Arch; 1997 May; 430(5):355-64. PubMed ID: 9174625
[TBL] [Abstract][Full Text] [Related]
20. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
Huang GZ; Lo YL
J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
